| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 258 | 2024 | 4641 | 20.120 |
Why?
|
| Fear | 130 | 2024 | 1494 | 18.870 |
Why?
|
| Amygdala | 79 | 2024 | 1382 | 9.550 |
Why?
|
| Extinction, Psychological | 55 | 2023 | 371 | 9.300 |
Why?
|
| Conditioning, Classical | 49 | 2024 | 370 | 7.530 |
Why?
|
| Tacrolimus Binding Proteins | 16 | 2024 | 199 | 4.710 |
Why?
|
| Brain-Derived Neurotrophic Factor | 23 | 2024 | 607 | 4.260 |
Why?
|
| Memory | 31 | 2024 | 2210 | 4.150 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 14 | 2022 | 53 | 3.760 |
Why?
|
| Implosive Therapy | 12 | 2021 | 127 | 3.390 |
Why?
|
| Child Abuse | 36 | 2023 | 1096 | 3.370 |
Why?
|
| Anxiety Disorders | 27 | 2023 | 2754 | 2.920 |
Why?
|
| Neuronal Plasticity | 19 | 2024 | 1448 | 2.790 |
Why?
|
| Learning | 20 | 2023 | 1761 | 2.780 |
Why?
|
| Corticotropin-Releasing Hormone | 19 | 2021 | 360 | 2.630 |
Why?
|
| Cycloserine | 11 | 2019 | 118 | 2.390 |
Why?
|
| Dissociative Disorders | 10 | 2024 | 235 | 2.380 |
Why?
|
| Brain | 77 | 2024 | 27454 | 2.320 |
Why?
|
| Adult Survivors of Child Abuse | 15 | 2023 | 301 | 2.260 |
Why?
|
| Epigenesis, Genetic | 32 | 2024 | 3827 | 2.160 |
Why?
|
| Receptor, trkB | 11 | 2017 | 125 | 2.160 |
Why?
|
| Pituitary-Adrenal System | 13 | 2024 | 557 | 2.010 |
Why?
|
| Anxiety | 33 | 2023 | 4677 | 2.000 |
Why?
|
| Hypothalamo-Hypophyseal System | 13 | 2024 | 705 | 2.000 |
Why?
|
| Stress, Psychological | 27 | 2024 | 4543 | 1.980 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 9 | 2024 | 108 | 1.930 |
Why?
|
| Receptors, Glucocorticoid | 8 | 2024 | 309 | 1.870 |
Why?
|
| Behavior | 4 | 2023 | 543 | 1.830 |
Why?
|
| Hippocampus | 28 | 2024 | 3784 | 1.820 |
Why?
|
| Life Change Events | 19 | 2021 | 962 | 1.820 |
Why?
|
| Prefrontal Cortex | 22 | 2024 | 2257 | 1.780 |
Why?
|
| Neurons | 29 | 2024 | 9513 | 1.690 |
Why?
|
| Neural Pathways | 17 | 2023 | 3121 | 1.660 |
Why?
|
| Depressive Disorder, Major | 28 | 2024 | 4819 | 1.650 |
Why?
|
| Urban Population | 21 | 2017 | 2045 | 1.640 |
Why?
|
| Resilience, Psychological | 13 | 2024 | 805 | 1.620 |
Why?
|
| Receptors, GABA-A | 7 | 2013 | 625 | 1.610 |
Why?
|
| Anti-Anxiety Agents | 6 | 2014 | 405 | 1.590 |
Why?
|
| Association Learning | 9 | 2015 | 223 | 1.590 |
Why?
|
| Epigenomics | 11 | 2023 | 959 | 1.530 |
Why?
|
| Veterans | 18 | 2023 | 2671 | 1.460 |
Why?
|
| Alprazolam | 4 | 2016 | 103 | 1.440 |
Why?
|
| Behavior, Animal | 22 | 2023 | 1879 | 1.430 |
Why?
|
| DNA Methylation | 29 | 2024 | 4421 | 1.430 |
Why?
|
| Military Personnel | 13 | 2024 | 1266 | 1.410 |
Why?
|
| Animals | 171 | 2024 | 169337 | 1.380 |
Why?
|
| Genetic Predisposition to Disease | 49 | 2024 | 18048 | 1.370 |
Why?
|
| Polymorphism, Single Nucleotide | 48 | 2024 | 16028 | 1.340 |
Why?
|
| Mental Disorders | 19 | 2021 | 6876 | 1.320 |
Why?
|
| Cholecystokinin | 5 | 2014 | 115 | 1.290 |
Why?
|
| Phobic Disorders | 6 | 2014 | 441 | 1.280 |
Why?
|
| Depression | 34 | 2023 | 8241 | 1.270 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2015 | 137 | 1.250 |
Why?
|
| Wounds and Injuries | 16 | 2021 | 2514 | 1.250 |
Why?
|
| Emotions | 19 | 2023 | 2768 | 1.250 |
Why?
|
| Genome-Wide Association Study | 46 | 2024 | 12778 | 1.240 |
Why?
|
| Humans | 389 | 2024 | 768393 | 1.230 |
Why?
|
| Olfactory Pathways | 6 | 2013 | 133 | 1.200 |
Why?
|
| Male | 260 | 2024 | 364902 | 1.170 |
Why?
|
| Tachykinins | 3 | 2018 | 77 | 1.120 |
Why?
|
| Mice, Inbred C57BL | 51 | 2024 | 22355 | 1.120 |
Why?
|
| Mice | 98 | 2024 | 82017 | 1.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 7 | 2018 | 88 | 1.110 |
Why?
|
| Smell | 7 | 2014 | 261 | 1.080 |
Why?
|
| Gene Expression Regulation | 27 | 2021 | 11918 | 1.070 |
Why?
|
| Sex Characteristics | 12 | 2024 | 2660 | 1.050 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 4 | 2015 | 327 | 1.040 |
Why?
|
| Cues | 14 | 2023 | 884 | 1.040 |
Why?
|
| Autonomic Nervous System | 4 | 2022 | 709 | 1.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2024 | 731 | 0.990 |
Why?
|
| Social Environment | 6 | 2016 | 1018 | 0.980 |
Why?
|
| Neurosciences | 5 | 2019 | 385 | 0.950 |
Why?
|
| Alcoholism | 7 | 2022 | 1982 | 0.940 |
Why?
|
| Female | 237 | 2024 | 397089 | 0.940 |
Why?
|
| Adult | 181 | 2024 | 223640 | 0.940 |
Why?
|
| Receptors, Odorant | 13 | 2018 | 67 | 0.940 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2015 | 905 | 0.920 |
Why?
|
| Transcranial Magnetic Stimulation | 4 | 2024 | 1489 | 0.900 |
Why?
|
| Maze Learning | 8 | 2013 | 484 | 0.880 |
Why?
|
| Septal Nuclei | 6 | 2015 | 84 | 0.870 |
Why?
|
| Freezing Reaction, Cataleptic | 6 | 2015 | 40 | 0.870 |
Why?
|
| Obsessive-Compulsive Disorder | 5 | 2023 | 1509 | 0.860 |
Why?
|
| Psychiatry | 5 | 2020 | 1715 | 0.850 |
Why?
|
| Nerve Net | 16 | 2023 | 2362 | 0.850 |
Why?
|
| Protein Precursors | 3 | 2018 | 1134 | 0.840 |
Why?
|
| Georgia | 14 | 2017 | 186 | 0.840 |
Why?
|
| Signal Transduction | 21 | 2024 | 23631 | 0.830 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2023 | 131 | 0.830 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 344 | 0.820 |
Why?
|
| Olfactory Bulb | 5 | 2019 | 198 | 0.820 |
Why?
|
| beta Catenin | 4 | 2012 | 1047 | 0.820 |
Why?
|
| Diffusion Tensor Imaging | 15 | 2024 | 2426 | 0.810 |
Why?
|
| Genotype | 27 | 2021 | 13042 | 0.810 |
Why?
|
| Substance-Related Disorders | 9 | 2023 | 4429 | 0.800 |
Why?
|
| Poverty | 8 | 2013 | 2721 | 0.800 |
Why?
|
| Genetic Association Studies | 9 | 2019 | 2742 | 0.800 |
Why?
|
| Gyrus Cinguli | 8 | 2023 | 1137 | 0.800 |
Why?
|
| Receptor, Cholecystokinin B | 2 | 2014 | 6 | 0.800 |
Why?
|
| Lentivirus | 8 | 2014 | 519 | 0.790 |
Why?
|
| Stress Disorders, Traumatic | 2 | 2019 | 50 | 0.780 |
Why?
|
| Stress, Physiological | 4 | 2021 | 1410 | 0.780 |
Why?
|
| Blinking | 3 | 2020 | 134 | 0.780 |
Why?
|
| Hydrocortisone | 12 | 2022 | 1841 | 0.770 |
Why?
|
| Thyroid Hormones | 1 | 2024 | 407 | 0.760 |
Why?
|
| Depressive Disorder | 8 | 2017 | 3736 | 0.730 |
Why?
|
| Juvenile Delinquency | 1 | 2021 | 116 | 0.710 |
Why?
|
| Young Adult | 77 | 2024 | 60049 | 0.710 |
Why?
|
| Dexamethasone | 15 | 2020 | 1965 | 0.700 |
Why?
|
| Locomotion | 4 | 2016 | 390 | 0.700 |
Why?
|
| Criminals | 1 | 2021 | 60 | 0.700 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2020 | 501 | 0.690 |
Why?
|
| Habituation, Psychophysiologic | 4 | 2016 | 148 | 0.690 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2021 | 167 | 0.680 |
Why?
|
| Middle Aged | 135 | 2024 | 223491 | 0.680 |
Why?
|
| Mood Disorders | 7 | 2013 | 1129 | 0.680 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2021 | 487 | 0.670 |
Why?
|
| Glutamate Decarboxylase | 3 | 2012 | 239 | 0.670 |
Why?
|
| Exploratory Behavior | 4 | 2015 | 276 | 0.670 |
Why?
|
| Violence | 6 | 2023 | 938 | 0.670 |
Why?
|
| Piperidines | 9 | 2016 | 1659 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2024 | 36849 | 0.650 |
Why?
|
| Heart Rate | 7 | 2024 | 4218 | 0.650 |
Why?
|
| Attention | 7 | 2019 | 2425 | 0.630 |
Why?
|
| Psychiatric Status Rating Scales | 24 | 2021 | 6034 | 0.630 |
Why?
|
| Arousal | 6 | 2019 | 1183 | 0.620 |
Why?
|
| Facial Expression | 10 | 2019 | 515 | 0.620 |
Why?
|
| Angiotensins | 2 | 2018 | 141 | 0.620 |
Why?
|
| Child Abuse, Sexual | 3 | 2010 | 404 | 0.620 |
Why?
|
| Synaptic Transmission | 6 | 2014 | 1175 | 0.620 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 11 | 2021 | 1990 | 0.610 |
Why?
|
| Acoustic Stimulation | 8 | 2016 | 1253 | 0.610 |
Why?
|
| Afghan Campaign 2001- | 2 | 2017 | 298 | 0.600 |
Why?
|
| CpG Islands | 15 | 2024 | 1209 | 0.600 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1794 | 0.600 |
Why?
|
| Mice, Transgenic | 20 | 2021 | 9562 | 0.600 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2018 | 146 | 0.590 |
Why?
|
| Receptors, Neurokinin-3 | 2 | 2016 | 59 | 0.590 |
Why?
|
| Desensitization, Psychologic | 2 | 2010 | 27 | 0.590 |
Why?
|
| Parenting | 1 | 2024 | 708 | 0.590 |
Why?
|
| Adolescent | 76 | 2024 | 89184 | 0.580 |
Why?
|
| Vagus Nerve | 1 | 2020 | 460 | 0.580 |
Why?
|
| RNA, Messenger | 24 | 2021 | 12805 | 0.580 |
Why?
|
| Avoidance Learning | 5 | 2017 | 249 | 0.580 |
Why?
|
| Disease Models, Animal | 20 | 2023 | 18362 | 0.570 |
Why?
|
| Olfactory Mucosa | 4 | 2015 | 101 | 0.570 |
Why?
|
| Losartan | 3 | 2021 | 263 | 0.560 |
Why?
|
| Transfection | 5 | 2013 | 5764 | 0.550 |
Why?
|
| Brain Mapping | 12 | 2023 | 6740 | 0.550 |
Why?
|
| Geriatric Psychiatry | 1 | 2017 | 70 | 0.550 |
Why?
|
| Combat Disorders | 2 | 2017 | 301 | 0.550 |
Why?
|
| MicroRNAs | 4 | 2019 | 3804 | 0.550 |
Why?
|
| Pleasure | 1 | 2016 | 41 | 0.540 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 4 | 2024 | 121 | 0.530 |
Why?
|
| Cerebrum | 2 | 2016 | 132 | 0.520 |
Why?
|
| Happiness | 2 | 2016 | 170 | 0.510 |
Why?
|
| Sodium Channels | 1 | 2017 | 341 | 0.510 |
Why?
|
| Nausea | 1 | 2018 | 682 | 0.500 |
Why?
|
| Renin-Angiotensin System | 3 | 2020 | 739 | 0.490 |
Why?
|
| Carrier Proteins | 8 | 2015 | 4936 | 0.490 |
Why?
|
| Mammals | 4 | 2022 | 1136 | 0.490 |
Why?
|
| Galvanic Skin Response | 4 | 2021 | 359 | 0.470 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 263 | 0.470 |
Why?
|
| Dendritic Spines | 2 | 2018 | 244 | 0.470 |
Why?
|
| Sensory Receptor Cells | 3 | 2016 | 508 | 0.470 |
Why?
|
| Toxoplasmosis | 3 | 2021 | 94 | 0.460 |
Why?
|
| Neurobiology | 2 | 2024 | 137 | 0.460 |
Why?
|
| Evoked Potentials | 1 | 2020 | 1058 | 0.460 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2021 | 1066 | 0.460 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 1739 | 0.460 |
Why?
|
| Affect | 4 | 2018 | 1501 | 0.460 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3857 | 0.450 |
Why?
|
| Neurokinin B | 1 | 2014 | 67 | 0.450 |
Why?
|
| Proteoglycans | 1 | 2017 | 807 | 0.450 |
Why?
|
| Patch-Clamp Techniques | 5 | 2023 | 927 | 0.440 |
Why?
|
| Ribonuclease III | 1 | 2015 | 270 | 0.440 |
Why?
|
| Neuropeptide Y | 2 | 2012 | 194 | 0.440 |
Why?
|
| Nootropic Agents | 1 | 2014 | 159 | 0.440 |
Why?
|
| Olfactory Receptor Neurons | 4 | 2008 | 96 | 0.430 |
Why?
|
| Child | 52 | 2023 | 80891 | 0.430 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2015 | 326 | 0.430 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 1517 | 0.430 |
Why?
|
| Geniculate Bodies | 1 | 2014 | 159 | 0.430 |
Why?
|
| Auditory Cortex | 1 | 2017 | 365 | 0.430 |
Why?
|
| Paternal Exposure | 1 | 2013 | 99 | 0.420 |
Why?
|
| Receptors, GABA | 1 | 2015 | 313 | 0.420 |
Why?
|
| Rats | 28 | 2021 | 23835 | 0.420 |
Why?
|
| Polyethyleneimine | 1 | 2013 | 68 | 0.420 |
Why?
|
| Glutamic Acid | 4 | 2023 | 1193 | 0.420 |
Why?
|
| Receptors, Opioid | 1 | 2013 | 145 | 0.420 |
Why?
|
| In Situ Hybridization | 11 | 2012 | 1905 | 0.410 |
Why?
|
| Models, Genetic | 6 | 2019 | 3442 | 0.410 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2013 | 74 | 0.410 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 636 | 0.410 |
Why?
|
| Estradiol | 3 | 2017 | 1952 | 0.410 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.410 |
Why?
|
| Genetic Loci | 4 | 2024 | 2630 | 0.410 |
Why?
|
| Panic Disorder | 3 | 2013 | 613 | 0.410 |
Why?
|
| Photic Stimulation | 9 | 2016 | 2004 | 0.410 |
Why?
|
| Accidents, Traffic | 7 | 2022 | 819 | 0.410 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2015 | 775 | 0.410 |
Why?
|
| Proteomics | 4 | 2023 | 3906 | 0.400 |
Why?
|
| Promoter Regions, Genetic | 6 | 2014 | 5801 | 0.400 |
Why?
|
| Opioid Peptides | 1 | 2012 | 37 | 0.400 |
Why?
|
| Corpus Striatum | 6 | 2024 | 1237 | 0.400 |
Why?
|
| Insanity Defense | 1 | 2012 | 28 | 0.390 |
Why?
|
| Personality Inventory | 7 | 2013 | 1018 | 0.390 |
Why?
|
| Risk Factors | 47 | 2024 | 74962 | 0.390 |
Why?
|
| Lipoproteins, LDL | 2 | 2022 | 643 | 0.390 |
Why?
|
| Appetite | 1 | 2014 | 247 | 0.390 |
Why?
|
| Wnt Proteins | 2 | 2016 | 724 | 0.390 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 29 | 0.380 |
Why?
|
| Alleles | 12 | 2023 | 6892 | 0.380 |
Why?
|
| Environment | 3 | 2016 | 1124 | 0.380 |
Why?
|
| Patient Care Planning | 1 | 2017 | 904 | 0.380 |
Why?
|
| Sex Factors | 14 | 2022 | 10654 | 0.380 |
Why?
|
| Neuropsychological Tests | 11 | 2017 | 7145 | 0.380 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 123 | 0.380 |
Why?
|
| Feeding Behavior | 2 | 2023 | 3203 | 0.370 |
Why?
|
| Risperidone | 1 | 2013 | 383 | 0.370 |
Why?
|
| Corticosterone | 6 | 2021 | 301 | 0.370 |
Why?
|
| Polymorphism, Genetic | 5 | 2016 | 4250 | 0.370 |
Why?
|
| Analysis of Variance | 11 | 2015 | 6241 | 0.370 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 429 | 0.360 |
Why?
|
| Flavanones | 1 | 2010 | 75 | 0.360 |
Why?
|
| Lipoproteins, HDL | 2 | 2022 | 682 | 0.360 |
Why?
|
| Genetic Variation | 6 | 2018 | 6606 | 0.360 |
Why?
|
| Neurotensin | 2 | 2022 | 60 | 0.350 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2012 | 1143 | 0.340 |
Why?
|
| Expert Testimony | 1 | 2012 | 266 | 0.340 |
Why?
|
| Suicide, Attempted | 4 | 2014 | 1409 | 0.340 |
Why?
|
| Longitudinal Studies | 19 | 2024 | 14784 | 0.340 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 7955 | 0.340 |
Why?
|
| Green Fluorescent Proteins | 8 | 2016 | 2069 | 0.340 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2018 | 179 | 0.340 |
Why?
|
| Phenotype | 20 | 2024 | 16721 | 0.330 |
Why?
|
| Receptors, Notch | 1 | 2014 | 751 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 6 | 2015 | 4414 | 0.330 |
Why?
|
| Hypnosis | 1 | 2010 | 84 | 0.330 |
Why?
|
| Affective Symptoms | 3 | 2016 | 418 | 0.330 |
Why?
|
| Reward | 4 | 2024 | 984 | 0.320 |
Why?
|
| Suicide | 3 | 2016 | 1607 | 0.320 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2013 | 2433 | 0.320 |
Why?
|
| Mental Recall | 4 | 2016 | 1226 | 0.320 |
Why?
|
| Anisotropy | 6 | 2024 | 1296 | 0.320 |
Why?
|
| Synapses | 4 | 2024 | 1766 | 0.320 |
Why?
|
| Hypothalamus | 7 | 2024 | 1004 | 0.320 |
Why?
|
| Face | 1 | 2015 | 1031 | 0.320 |
Why?
|
| Sensory Gating | 1 | 2009 | 47 | 0.320 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 26375 | 0.320 |
Why?
|
| Psychopathology | 4 | 2023 | 435 | 0.320 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 494 | 0.320 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 3080 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2021 | 8199 | 0.310 |
Why?
|
| Community Mental Health Centers | 2 | 2008 | 93 | 0.310 |
Why?
|
| Temporal Lobe | 5 | 2020 | 1728 | 0.310 |
Why?
|
| Acetophenones | 5 | 2018 | 52 | 0.310 |
Why?
|
| Electroconvulsive Therapy | 3 | 2021 | 502 | 0.300 |
Why?
|
| Psychophysiology | 2 | 2021 | 137 | 0.300 |
Why?
|
| Molecular Biology | 1 | 2012 | 573 | 0.300 |
Why?
|
| Dependovirus | 1 | 2013 | 721 | 0.300 |
Why?
|
| Comprehension | 1 | 2013 | 641 | 0.300 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 371 | 0.300 |
Why?
|
| Severity of Illness Index | 17 | 2019 | 15939 | 0.300 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 953 | 0.290 |
Why?
|
| Toxoplasma | 2 | 2021 | 159 | 0.290 |
Why?
|
| Models, Neurological | 3 | 2014 | 1783 | 0.290 |
Why?
|
| Motor Vehicles | 7 | 2023 | 282 | 0.290 |
Why?
|
| Integrases | 4 | 2016 | 520 | 0.290 |
Why?
|
| Estrogens | 5 | 2017 | 1534 | 0.290 |
Why?
|
| Endocannabinoids | 1 | 2008 | 113 | 0.290 |
Why?
|
| Triglycerides | 2 | 2022 | 2465 | 0.280 |
Why?
|
| Receptors, Cannabinoid | 1 | 2007 | 43 | 0.280 |
Why?
|
| Wrist | 3 | 2024 | 232 | 0.280 |
Why?
|
| Norepinephrine | 2 | 2000 | 900 | 0.280 |
Why?
|
| Quantitative Trait Loci | 4 | 2016 | 2127 | 0.280 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 310 | 0.280 |
Why?
|
| Benzodiazepines | 2 | 2010 | 1139 | 0.270 |
Why?
|
| Spatial Behavior | 1 | 2007 | 89 | 0.270 |
Why?
|
| Protein Kinase C-delta | 2 | 2018 | 115 | 0.270 |
Why?
|
| Patient Discharge | 2 | 2019 | 3476 | 0.270 |
Why?
|
| Phylogeny | 1 | 2014 | 2843 | 0.270 |
Why?
|
| Mice, Knockout | 12 | 2018 | 14481 | 0.270 |
Why?
|
| Motor Activity | 6 | 2018 | 2720 | 0.270 |
Why?
|
| Aged | 52 | 2023 | 171562 | 0.270 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 8562 | 0.260 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1755 | 0.260 |
Why?
|
| Minority Groups | 1 | 2013 | 1215 | 0.260 |
Why?
|
| Dyslipidemias | 1 | 2013 | 873 | 0.260 |
Why?
|
| GABA Modulators | 1 | 2006 | 109 | 0.260 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 717 | 0.260 |
Why?
|
| Citalopram | 3 | 2015 | 401 | 0.260 |
Why?
|
| Dopamine | 3 | 2018 | 1617 | 0.260 |
Why?
|
| Habenula | 1 | 2006 | 39 | 0.260 |
Why?
|
| Gene Deletion | 4 | 2021 | 2673 | 0.250 |
Why?
|
| Prosencephalon | 1 | 2007 | 306 | 0.250 |
Why?
|
| Genes, Reporter | 3 | 2016 | 1524 | 0.250 |
Why?
|
| Mesencephalon | 1 | 2007 | 339 | 0.250 |
Why?
|
| Prospective Studies | 19 | 2024 | 54920 | 0.250 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 15649 | 0.250 |
Why?
|
| Electromyography | 6 | 2018 | 1402 | 0.250 |
Why?
|
| Down-Regulation | 5 | 2020 | 2940 | 0.250 |
Why?
|
| Length of Stay | 1 | 2019 | 6519 | 0.240 |
Why?
|
| Schizophrenia | 7 | 2023 | 6987 | 0.240 |
Why?
|
| Glucocorticoids | 7 | 2023 | 2168 | 0.240 |
Why?
|
| Residence Characteristics | 4 | 2024 | 2122 | 0.240 |
Why?
|
| Genetic Vectors | 6 | 2013 | 3413 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 3712 | 0.240 |
Why?
|
| Demography | 5 | 2021 | 1642 | 0.230 |
Why?
|
| Social Behavior | 5 | 2023 | 1146 | 0.230 |
Why?
|
| Midazolam | 1 | 2006 | 267 | 0.230 |
Why?
|
| Psychometrics | 6 | 2021 | 3069 | 0.230 |
Why?
|
| Self Report | 11 | 2023 | 3766 | 0.230 |
Why?
|
| Crime | 2 | 2015 | 206 | 0.230 |
Why?
|
| Genetic Markers | 5 | 2016 | 2604 | 0.230 |
Why?
|
| Flavones | 3 | 2017 | 66 | 0.230 |
Why?
|
| Adaptation, Psychological | 5 | 2017 | 2663 | 0.230 |
Why?
|
| Pain | 5 | 2023 | 5103 | 0.230 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 1895 | 0.230 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.220 |
Why?
|
| Urban Health Services | 1 | 2005 | 177 | 0.220 |
Why?
|
| Survivors | 6 | 2024 | 2382 | 0.220 |
Why?
|
| Melanocortins | 1 | 2023 | 10 | 0.220 |
Why?
|
| Trauma Severity Indices | 3 | 2021 | 479 | 0.220 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2024 | 202 | 0.220 |
Why?
|
| Gene Expression | 10 | 2019 | 7598 | 0.220 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 3836 | 0.220 |
Why?
|
| Cohort Studies | 21 | 2024 | 41795 | 0.220 |
Why?
|
| Tetrazoles | 1 | 2009 | 923 | 0.220 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 335 | 0.220 |
Why?
|
| Telemedicine | 2 | 2019 | 3107 | 0.210 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2017 | 142 | 0.210 |
Why?
|
| Aggression | 3 | 2019 | 750 | 0.210 |
Why?
|
| Gene Frequency | 6 | 2021 | 3617 | 0.210 |
Why?
|
| Thalamus | 3 | 2019 | 1050 | 0.210 |
Why?
|
| Models, Psychological | 4 | 2023 | 828 | 0.210 |
Why?
|
| Hashimoto Disease | 1 | 2024 | 108 | 0.210 |
Why?
|
| Receptors, Adrenergic, beta-2 | 4 | 2015 | 216 | 0.210 |
Why?
|
| Inflammation | 8 | 2023 | 10863 | 0.200 |
Why?
|
| Response Elements | 3 | 2015 | 308 | 0.200 |
Why?
|
| Cerebral Cortex | 5 | 2024 | 5831 | 0.200 |
Why?
|
| Long-Term Potentiation | 1 | 2024 | 290 | 0.200 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2027 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2014 | 9063 | 0.200 |
Why?
|
| Electroshock | 4 | 2013 | 120 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 1188 | 0.200 |
Why?
|
| Internal Capsule | 1 | 2023 | 138 | 0.200 |
Why?
|
| Cognition | 5 | 2021 | 7075 | 0.190 |
Why?
|
| Neural Inhibition | 1 | 2006 | 588 | 0.190 |
Why?
|
| Precipitating Factors | 1 | 2021 | 51 | 0.190 |
Why?
|
| Linkage Disequilibrium | 7 | 2021 | 1998 | 0.190 |
Why?
|
| Punishment | 1 | 2022 | 95 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7880 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 2537 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2020 | 2986 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 146 | 0.190 |
Why?
|
| Models, Animal | 3 | 2020 | 2124 | 0.190 |
Why?
|
| Pyrazoles | 4 | 2015 | 2021 | 0.180 |
Why?
|
| Socioeconomic Factors | 6 | 2012 | 7861 | 0.180 |
Why?
|
| Immobilization | 2 | 2013 | 230 | 0.180 |
Why?
|
| Hospitals, Psychiatric | 2 | 2019 | 318 | 0.180 |
Why?
|
| Ventral Tegmental Area | 2 | 2019 | 136 | 0.180 |
Why?
|
| Statistics as Topic | 3 | 2013 | 2363 | 0.180 |
Why?
|
| Criminal Law | 1 | 2021 | 97 | 0.180 |
Why?
|
| Aging | 6 | 2023 | 8764 | 0.180 |
Why?
|
| Depersonalization | 1 | 2020 | 40 | 0.180 |
Why?
|
| Treatment Outcome | 18 | 2021 | 65379 | 0.180 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12456 | 0.180 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 71 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1923 | 0.170 |
Why?
|
| Rape | 2 | 2012 | 131 | 0.170 |
Why?
|
| Bullying | 1 | 2023 | 234 | 0.170 |
Why?
|
| Interneurons | 2 | 2019 | 593 | 0.170 |
Why?
|
| Psychotherapy | 4 | 2023 | 1656 | 0.170 |
Why?
|
| Psychotropic Drugs | 2 | 2015 | 884 | 0.170 |
Why?
|
| Risk Assessment | 5 | 2024 | 24318 | 0.170 |
Why?
|
| Individuality | 1 | 2021 | 307 | 0.170 |
Why?
|
| Habits | 2 | 2017 | 147 | 0.170 |
Why?
|
| Isoenzymes | 1 | 2004 | 1684 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2038 | 0.170 |
Why?
|
| Scopolamine | 1 | 2019 | 93 | 0.170 |
Why?
|
| Alternative Splicing | 1 | 2004 | 1093 | 0.160 |
Why?
|
| Cholinergic Agents | 1 | 2019 | 97 | 0.160 |
Why?
|
| Cannabis | 2 | 2023 | 445 | 0.160 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 293 | 0.160 |
Why?
|
| Pituitary-Adrenal Function Tests | 4 | 2012 | 30 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2014 | 2524 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8051 | 0.160 |
Why?
|
| Genes, fos | 1 | 2019 | 176 | 0.160 |
Why?
|
| Crime Victims | 1 | 2023 | 347 | 0.160 |
Why?
|
| Endocrine System | 1 | 2019 | 113 | 0.160 |
Why?
|
| Antidepressive Agents | 4 | 2017 | 2913 | 0.160 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 6 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 10776 | 0.160 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2017 | 86 | 0.150 |
Why?
|
| Ethanol | 2 | 2022 | 1332 | 0.150 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 227 | 0.150 |
Why?
|
| Microinjections | 2 | 2011 | 323 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2023 | 739 | 0.150 |
Why?
|
| Cell Line | 7 | 2016 | 15597 | 0.150 |
Why?
|
| Risk | 7 | 2019 | 9636 | 0.150 |
Why?
|
| Cytokines | 2 | 2024 | 7445 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4357 | 0.150 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 2188 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2021 | 373 | 0.150 |
Why?
|
| Clozapine | 2 | 2016 | 508 | 0.150 |
Why?
|
| Social Class | 2 | 2019 | 2009 | 0.150 |
Why?
|
| Ondansetron | 1 | 2018 | 95 | 0.150 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 136 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2013 | 3464 | 0.150 |
Why?
|
| Linguistics | 1 | 2018 | 110 | 0.140 |
Why?
|
| Cells, Cultured | 6 | 2021 | 19022 | 0.140 |
Why?
|
| Muscimol | 1 | 2017 | 70 | 0.140 |
Why?
|
| Designer Drugs | 1 | 2017 | 21 | 0.140 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 150 | 0.140 |
Why?
|
| Regression Analysis | 6 | 2014 | 6350 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 2020 | 1337 | 0.140 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1248 | 0.140 |
Why?
|
| Telemetry | 1 | 2018 | 200 | 0.140 |
Why?
|
| Comorbidity | 8 | 2023 | 10588 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1658 | 0.140 |
Why?
|
| Bipolar Disorder | 4 | 2017 | 5126 | 0.140 |
Why?
|
| Antiemetics | 1 | 2018 | 188 | 0.140 |
Why?
|
| Receptors, Neurotensin | 1 | 2016 | 16 | 0.140 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 437 | 0.140 |
Why?
|
| Racemases and Epimerases | 1 | 2017 | 114 | 0.140 |
Why?
|
| Multifactorial Inheritance | 3 | 2021 | 1421 | 0.140 |
Why?
|
| N-Methylaspartate | 1 | 2017 | 231 | 0.140 |
Why?
|
| Urban Health | 3 | 2018 | 535 | 0.130 |
Why?
|
| Immunohistochemistry | 6 | 2017 | 11120 | 0.130 |
Why?
|
| Eating | 1 | 2023 | 1541 | 0.130 |
Why?
|
| Cerebellum | 1 | 2024 | 1514 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2018 | 411 | 0.130 |
Why?
|
| Genomics | 8 | 2021 | 5916 | 0.130 |
Why?
|
| Introns | 2 | 2016 | 968 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2017 | 812 | 0.130 |
Why?
|
| Safety | 1 | 2021 | 1159 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 794 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2016 | 69 | 0.130 |
Why?
|
| Sexual Maturation | 1 | 2017 | 261 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2016 | 195 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2276 | 0.130 |
Why?
|
| Haplotypes | 3 | 2019 | 2724 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2016 | 58 | 0.130 |
Why?
|
| Autophagy | 1 | 2024 | 1351 | 0.130 |
Why?
|
| Narration | 1 | 2018 | 221 | 0.130 |
Why?
|
| Somatostatin | 1 | 2018 | 458 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2017 | 242 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 329 | 0.130 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9510 | 0.130 |
Why?
|
| Alcohol Drinking | 3 | 2022 | 4049 | 0.130 |
Why?
|
| Case-Control Studies | 12 | 2022 | 22296 | 0.130 |
Why?
|
| Child Behavior | 1 | 2021 | 865 | 0.130 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 71 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 2708 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1493 | 0.120 |
Why?
|
| Decision Making | 3 | 2015 | 3953 | 0.120 |
Why?
|
| Linear Models | 5 | 2017 | 5878 | 0.120 |
Why?
|
| Cadherins | 2 | 2011 | 906 | 0.120 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 306 | 0.120 |
Why?
|
| Adjustment Disorders | 1 | 2015 | 68 | 0.120 |
Why?
|
| Gene Targeting | 2 | 2010 | 841 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2013 | 1203 | 0.120 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 72 | 0.120 |
Why?
|
| Serotonin | 1 | 2000 | 1045 | 0.120 |
Why?
|
| Receptors, Glutamate | 2 | 2006 | 229 | 0.120 |
Why?
|
| United States | 11 | 2024 | 73150 | 0.120 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2015 | 69 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 259 | 0.120 |
Why?
|
| Culture | 1 | 2019 | 623 | 0.120 |
Why?
|
| Technology | 1 | 2017 | 296 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2015 | 153 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2018 | 463 | 0.120 |
Why?
|
| Leadership | 1 | 2024 | 1395 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2017 | 443 | 0.120 |
Why?
|
| DNA Primers | 2 | 2012 | 2825 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2015 | 139 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1141 | 0.120 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2014 | 7 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 133 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1881 | 0.120 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 753 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2015 | 178 | 0.120 |
Why?
|
| 1-Propanol | 1 | 2013 | 15 | 0.110 |
Why?
|
| Hospitals, Public | 2 | 2015 | 205 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2013 | 5037 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 1516 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2016 | 640 | 0.110 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 243 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 556 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 332 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 839 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2019 | 1337 | 0.110 |
Why?
|
| Spermatozoa | 2 | 2018 | 631 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2009 | 619 | 0.110 |
Why?
|
| Dialysis | 1 | 2013 | 73 | 0.110 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2013 | 108 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2015 | 196 | 0.110 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 357 | 0.110 |
Why?
|
| Amidohydrolases | 1 | 2014 | 160 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2046 | 0.110 |
Why?
|
| Serine | 1 | 2017 | 831 | 0.110 |
Why?
|
| Virus Cultivation | 1 | 2013 | 88 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 1110 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2010 | 413 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3794 | 0.110 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2013 | 298 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2568 | 0.110 |
Why?
|
| Ovariectomy | 1 | 2015 | 615 | 0.110 |
Why?
|
| Methylcellulose | 1 | 2013 | 34 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2023 | 1240 | 0.110 |
Why?
|
| Saliva | 2 | 2016 | 854 | 0.110 |
Why?
|
| Borderline Personality Disorder | 1 | 2021 | 767 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1890 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2024 | 4047 | 0.110 |
Why?
|
| Appetitive Behavior | 1 | 2012 | 39 | 0.110 |
Why?
|
| Parents | 2 | 2024 | 3596 | 0.110 |
Why?
|
| Pregnancy | 9 | 2022 | 30200 | 0.100 |
Why?
|
| Carbamates | 1 | 2014 | 192 | 0.100 |
Why?
|
| Rodentia | 2 | 2023 | 262 | 0.100 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 61 | 0.100 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 20224 | 0.100 |
Why?
|
| beta-Galactosidase | 1 | 2013 | 575 | 0.100 |
Why?
|
| Manganese Compounds | 1 | 2012 | 25 | 0.100 |
Why?
|
| Territoriality | 1 | 2011 | 6 | 0.100 |
Why?
|
| DNA | 4 | 2014 | 7211 | 0.100 |
Why?
|
| Phosphorus | 1 | 2013 | 336 | 0.100 |
Why?
|
| Nitrogen | 1 | 2013 | 345 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 457 | 0.100 |
Why?
|
| Visual Perception | 1 | 2020 | 1406 | 0.100 |
Why?
|
| Diazepam | 1 | 2012 | 214 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4588 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2257 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2016 | 877 | 0.100 |
Why?
|
| Hallucinogens | 1 | 2015 | 207 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 708 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2015 | 519 | 0.100 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 223 | 0.090 |
Why?
|
| Electronics | 2 | 2023 | 317 | 0.090 |
Why?
|
| Illinois | 1 | 2011 | 120 | 0.090 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2012 | 115 | 0.090 |
Why?
|
| Repression, Psychology | 1 | 2011 | 46 | 0.090 |
Why?
|
| Desipramine | 1 | 2011 | 183 | 0.090 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2011 | 39 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 874 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2019 | 1067 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2016 | 1194 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 855 | 0.090 |
Why?
|
| Cluster Analysis | 3 | 2014 | 2728 | 0.090 |
Why?
|
| Oxygen | 2 | 2013 | 4273 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3434 | 0.090 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2010 | 20 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3164 | 0.090 |
Why?
|
| Personality Assessment | 1 | 2013 | 646 | 0.090 |
Why?
|
| Brain Concussion | 1 | 2022 | 1433 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2570 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 74 | 0.090 |
Why?
|
| Pain Measurement | 3 | 2013 | 3581 | 0.090 |
Why?
|
| Limonins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Genes, Immediate-Early | 2 | 2019 | 102 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2019 | 2489 | 0.090 |
Why?
|
| RGS Proteins | 1 | 2010 | 76 | 0.090 |
Why?
|
| Pentylenetetrazole | 1 | 2010 | 72 | 0.090 |
Why?
|
| Eye Movement Desensitization Reprocessing | 1 | 2010 | 5 | 0.090 |
Why?
|
| Social Problems | 1 | 2011 | 108 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2010 | 8326 | 0.090 |
Why?
|
| Goals | 1 | 2015 | 716 | 0.090 |
Why?
|
| Glycine | 1 | 2013 | 672 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1743 | 0.090 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2013 | 328 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4142 | 0.090 |
Why?
|
| Models, Statistical | 5 | 2019 | 5099 | 0.090 |
Why?
|
| Mothers | 3 | 2022 | 2211 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1901 | 0.090 |
Why?
|
| Conditioning, Operant | 3 | 2017 | 311 | 0.080 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 84 | 0.080 |
Why?
|
| Nasal Mucosa | 1 | 1993 | 411 | 0.080 |
Why?
|
| Gerbillinae | 1 | 2009 | 87 | 0.080 |
Why?
|
| Executive Function | 2 | 2016 | 1405 | 0.080 |
Why?
|
| Psychophysics | 1 | 2010 | 291 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2024 | 8541 | 0.080 |
Why?
|
| Emotional Intelligence | 1 | 2011 | 135 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2013 | 545 | 0.080 |
Why?
|
| RNA | 3 | 2011 | 2726 | 0.080 |
Why?
|
| Extremities | 1 | 2015 | 870 | 0.080 |
Why?
|
| Social Support | 2 | 2011 | 2191 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2448 | 0.080 |
Why?
|
| Neuralgia | 1 | 2016 | 622 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1876 | 0.080 |
Why?
|
| Child Development | 1 | 2021 | 2334 | 0.080 |
Why?
|
| Primary Health Care | 3 | 2011 | 4748 | 0.080 |
Why?
|
| Prevalence | 7 | 2022 | 15872 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3695 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 1362 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3579 | 0.080 |
Why?
|
| Pregnant Women | 1 | 2014 | 577 | 0.080 |
Why?
|
| Pyridines | 2 | 2012 | 2889 | 0.080 |
Why?
|
| Titrimetry | 1 | 2009 | 36 | 0.080 |
Why?
|
| Time Factors | 9 | 2019 | 40272 | 0.080 |
Why?
|
| Communication | 1 | 2023 | 3912 | 0.080 |
Why?
|
| Limbic System | 1 | 2011 | 423 | 0.080 |
Why?
|
| Chlorides | 1 | 2012 | 663 | 0.080 |
Why?
|
| Personality | 1 | 2013 | 560 | 0.080 |
Why?
|
| Nerve Growth Factors | 2 | 2004 | 564 | 0.080 |
Why?
|
| Child, Preschool | 6 | 2023 | 42650 | 0.080 |
Why?
|
| RNA Interference | 2 | 2020 | 2836 | 0.080 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2010 | 289 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2698 | 0.080 |
Why?
|
| Lasers | 1 | 2013 | 952 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2014 | 8731 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2013 | 580 | 0.080 |
Why?
|
| Polymers | 1 | 2016 | 1630 | 0.080 |
Why?
|
| Pentagastrin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8747 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 867 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1380 | 0.080 |
Why?
|
| Action Potentials | 1 | 2016 | 1838 | 0.080 |
Why?
|
| Unemployment | 1 | 2010 | 210 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1135 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6234 | 0.080 |
Why?
|
| Lithium Chloride | 1 | 2008 | 83 | 0.080 |
Why?
|
| Prisoners | 1 | 2012 | 315 | 0.080 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2007 | 30 | 0.070 |
Why?
|
| Birth Weight | 1 | 2016 | 2114 | 0.070 |
Why?
|
| Mental Health | 1 | 2022 | 3276 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2019 | 12166 | 0.070 |
Why?
|
| Smoking | 2 | 2016 | 9111 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 367 | 0.070 |
Why?
|
| Hypertension | 2 | 2022 | 8615 | 0.070 |
Why?
|
| Friends | 1 | 2009 | 149 | 0.070 |
Why?
|
| Psychological Tests | 3 | 2019 | 643 | 0.070 |
Why?
|
| Domestic Violence | 1 | 2009 | 180 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2014 | 942 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1647 | 0.070 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 902 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2820 | 0.070 |
Why?
|
| Genome, Human | 3 | 2015 | 4450 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1246 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1438 | 0.070 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2010 | 492 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 30022 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2013 | 2268 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 9493 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 414 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1428 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2007 | 109 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 937 | 0.070 |
Why?
|
| Electrolysis | 1 | 2006 | 8 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2475 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 344 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3612 | 0.070 |
Why?
|
| Hospitalization | 3 | 2022 | 10844 | 0.060 |
Why?
|
| Apomorphine | 1 | 2006 | 150 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2911 | 0.060 |
Why?
|
| Antimetabolites | 1 | 2006 | 129 | 0.060 |
Why?
|
| Universities | 1 | 2011 | 1005 | 0.060 |
Why?
|
| Neocortex | 1 | 2010 | 417 | 0.060 |
Why?
|
| Logistic Models | 3 | 2016 | 13323 | 0.060 |
Why?
|
| Software | 2 | 2021 | 4453 | 0.060 |
Why?
|
| Pentanols | 1 | 2005 | 4 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 1893 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4120 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3312 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1614 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2592 | 0.060 |
Why?
|
| Time | 2 | 2018 | 546 | 0.060 |
Why?
|
| Syndrome | 1 | 2011 | 3275 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 59686 | 0.060 |
Why?
|
| Neurology | 1 | 2013 | 786 | 0.060 |
Why?
|
| Angola | 1 | 2024 | 18 | 0.060 |
Why?
|
| Indole Alkaloids | 1 | 2004 | 23 | 0.060 |
Why?
|
| Radiography | 1 | 2015 | 6993 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2695 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2008 | 638 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18471 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2014 | 1967 | 0.060 |
Why?
|
| Viral Load | 1 | 2013 | 3398 | 0.060 |
Why?
|
| Laboratories | 1 | 2007 | 463 | 0.060 |
Why?
|
| Plasmids | 1 | 2009 | 2268 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 1753 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2299 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 110 | 0.050 |
Why?
|
| Sirolimus | 1 | 2010 | 1542 | 0.050 |
Why?
|
| Transgenes | 1 | 2007 | 1015 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2024 | 4622 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 3838 | 0.050 |
Why?
|
| Heterozygote | 1 | 2010 | 2791 | 0.050 |
Why?
|
| Neurogranin | 1 | 2002 | 15 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1703 | 0.050 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 1462 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39407 | 0.050 |
Why?
|
| Carbazoles | 1 | 2004 | 221 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 1673 | 0.050 |
Why?
|
| DNA, Circular | 1 | 2022 | 97 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2002 | 203 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 288 | 0.050 |
Why?
|
| Darkness | 2 | 2012 | 160 | 0.050 |
Why?
|
| Testosterone | 1 | 2013 | 2493 | 0.050 |
Why?
|
| Thalamic Nuclei | 1 | 2022 | 111 | 0.050 |
Why?
|
| Neurites | 1 | 2024 | 390 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2023 | 6277 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1397 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 856 | 0.050 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2002 | 239 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2023 | 26411 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2005 | 786 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2007 | 936 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3279 | 0.050 |
Why?
|
| Systems Biology | 1 | 2024 | 479 | 0.040 |
Why?
|
| Afghanistan | 1 | 2020 | 77 | 0.040 |
Why?
|
| Reference Values | 2 | 2019 | 4941 | 0.040 |
Why?
|
| Leukocytes | 2 | 2020 | 2030 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10267 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 948 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2022 | 251 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1668 | 0.040 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 337 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2012 | 3048 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2588 | 0.040 |
Why?
|
| Kynurenine | 1 | 2020 | 142 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2024 | 559 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2006 | 1191 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 2000 | 155 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2005 | 886 | 0.040 |
Why?
|
| Policy | 1 | 2023 | 514 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2021 | 376 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2636 | 0.040 |
Why?
|
| Shame | 1 | 2019 | 80 | 0.040 |
Why?
|
| Reproduction | 2 | 2017 | 646 | 0.040 |
Why?
|
| Epithelium | 4 | 2004 | 1609 | 0.040 |
Why?
|
| ROC Curve | 2 | 2021 | 3623 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1882 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1209 | 0.040 |
Why?
|
| Cyclohexenes | 1 | 2018 | 15 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 2000 | 211 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2007 | 847 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 363 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2020 | 222 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2024 | 540 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5336 | 0.040 |
Why?
|
| Cordocentesis | 1 | 2018 | 10 | 0.040 |
Why?
|
| Exons | 1 | 2004 | 2392 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2022 | 540 | 0.040 |
Why?
|
| Organ Size | 1 | 2024 | 2268 | 0.040 |
Why?
|
| Algorithms | 3 | 2020 | 14154 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 882 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4526 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.040 |
Why?
|
| Uncertainty | 1 | 2023 | 759 | 0.040 |
Why?
|
| Infant | 4 | 2023 | 36510 | 0.040 |
Why?
|
| Canada | 1 | 2023 | 2139 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4209 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2019 | 251 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 716 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2024 | 848 | 0.040 |
Why?
|
| Aldehydes | 1 | 2018 | 170 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2018 | 145 | 0.040 |
Why?
|
| Locus Coeruleus | 1 | 1999 | 243 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1013 | 0.040 |
Why?
|
| Norway | 1 | 2018 | 501 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 862 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2024 | 2362 | 0.030 |
Why?
|
| Jews | 1 | 2019 | 358 | 0.030 |
Why?
|
| Multigene Family | 3 | 1996 | 1082 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2016 | 121 | 0.030 |
Why?
|
| Obesity | 2 | 2022 | 13084 | 0.030 |
Why?
|
| Pain Perception | 1 | 2018 | 198 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2017 | 145 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 753 | 0.030 |
Why?
|
| Asthma | 1 | 2015 | 6280 | 0.030 |
Why?
|
| Sensation | 1 | 2018 | 337 | 0.030 |
Why?
|
| Personality Disorders | 1 | 2021 | 729 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2023 | 1346 | 0.030 |
Why?
|
| Nose | 3 | 1996 | 523 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 12241 | 0.030 |
Why?
|
| Sleep | 2 | 2023 | 4802 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2015 | 39 | 0.030 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 13052 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2015 | 105 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3541 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 148 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2021 | 947 | 0.030 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 276 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 840 | 0.030 |
Why?
|
| Microglia | 1 | 2024 | 1374 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2022 | 1440 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2417 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2016 | 296 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2015 | 112 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 353 | 0.030 |
Why?
|
| Outpatients | 2 | 2018 | 1604 | 0.030 |
Why?
|
| Epilepsy | 1 | 2010 | 3326 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2019 | 9379 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17626 | 0.030 |
Why?
|
| Germ Cells | 1 | 2018 | 643 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1747 | 0.030 |
Why?
|
| Nepal | 1 | 2015 | 301 | 0.030 |
Why?
|
| Perception | 1 | 2020 | 1205 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2015 | 380 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1748 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 410 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13646 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 774 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1994 | 300 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1674 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12092 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 1994 | 13423 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2018 | 780 | 0.030 |
Why?
|
| Endosomes | 1 | 2016 | 525 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3722 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 11858 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2017 | 624 | 0.030 |
Why?
|
| Endocytosis | 2 | 2010 | 959 | 0.030 |
Why?
|
| Human Characteristics | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2912 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 662 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2017 | 518 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2012 | 40 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 500 | 0.030 |
Why?
|
| Catheterization | 2 | 2013 | 1431 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2877 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1762 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 2013 | 130 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2016 | 628 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 812 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 849 | 0.030 |
Why?
|
| South Africa | 1 | 2018 | 1871 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1623 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 1727 | 0.020 |
Why?
|
| Genes, RAG-1 | 1 | 2012 | 68 | 0.020 |
Why?
|
| Longevity | 1 | 2020 | 1077 | 0.020 |
Why?
|
| Mentally Ill Persons | 1 | 2013 | 126 | 0.020 |
Why?
|
| Arrhythmia, Sinus | 1 | 2012 | 48 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1994 | 2750 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1539 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3779 | 0.020 |
Why?
|
| Raphe Nuclei | 1 | 2012 | 105 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2011 | 256 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 706 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2013 | 280 | 0.020 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2011 | 18 | 0.020 |
Why?
|
| Psychotherapy, Brief | 1 | 2012 | 118 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2018 | 1361 | 0.020 |
Why?
|
| Cities | 1 | 2014 | 543 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 188 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 347 | 0.020 |
Why?
|
| Research Design | 2 | 2019 | 6210 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 707 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 103 | 0.020 |
Why?
|
| Respiratory Rate | 1 | 2012 | 180 | 0.020 |
Why?
|
| Curriculum | 1 | 2024 | 3776 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2015 | 588 | 0.020 |
Why?
|
| Forecasting | 1 | 2019 | 2948 | 0.020 |
Why?
|
| Health Personnel | 1 | 2024 | 3380 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1989 | 63 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 5512 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1989 | 75 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 3922 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5375 | 0.020 |
Why?
|
| Receptors, Vasopressin | 1 | 2010 | 106 | 0.020 |
Why?
|
| Valine | 1 | 2011 | 410 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2015 | 950 | 0.020 |
Why?
|
| Prejudice | 1 | 2014 | 574 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 431 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1989 | 114 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 824 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5794 | 0.020 |
Why?
|
| Methionine | 1 | 2011 | 573 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 847 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 303 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 47 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 577 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1890 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 2008 | 125 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4544 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1099 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1744 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4775 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 320 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2423 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2022 | 6430 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1515 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2200 | 0.020 |
Why?
|
| Motivation | 1 | 2017 | 2029 | 0.020 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 3413 | 0.020 |
Why?
|
| Biophysics | 1 | 2009 | 379 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 120 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2007 | 40 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3230 | 0.020 |
Why?
|
| Swimming | 1 | 2008 | 210 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2007 | 69 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 237 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 501 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 1890 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 924 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81801 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4570 | 0.020 |
Why?
|
| Axons | 1 | 1994 | 1678 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9371 | 0.020 |
Why?
|
| Health Surveys | 1 | 2016 | 4056 | 0.020 |
Why?
|
| Transportation | 1 | 2008 | 217 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2007 | 3663 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 1824 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2066 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1364 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 152 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5313 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
| Analgesics | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Flunitrazepam | 1 | 2005 | 20 | 0.020 |
Why?
|
| Protein Binding | 2 | 2010 | 9343 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 971 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 923 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2016 | 2083 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3543 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3587 | 0.010 |
Why?
|
| Lysine | 1 | 2009 | 988 | 0.010 |
Why?
|
| Motor Skills | 1 | 2007 | 523 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5151 | 0.010 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2004 | 110 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15455 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6085 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3666 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4291 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8753 | 0.010 |
Why?
|
| Family Health | 1 | 2008 | 1255 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1813 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 631 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5404 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2018 | 6317 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4875 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 12422 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4629 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 397 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 2002 | 116 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2002 | 612 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 5496 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3781 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3529 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4981 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1958 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1974 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6409 | 0.010 |
Why?
|
| Liver | 1 | 1993 | 7574 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14737 | 0.010 |
Why?
|
| Cations | 1 | 1995 | 240 | 0.010 |
Why?
|
| Health Status | 1 | 2008 | 4094 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1056 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 915 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9516 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 17135 | 0.010 |
Why?
|
| Vertebrates | 1 | 1994 | 227 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2004 | 1731 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7064 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 947 | 0.010 |
Why?
|
| Ion Channels | 1 | 1995 | 1044 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 2342 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4168 | 0.010 |
Why?
|
| Cilia | 1 | 1994 | 498 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2176 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1989 | 565 | 0.000 |
Why?
|
| Mass Screening | 1 | 2004 | 5451 | 0.000 |
Why?
|
| Amino Acids | 1 | 1989 | 1716 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11668 | 0.000 |
Why?
|
| Diet | 1 | 1989 | 8090 | 0.000 |
Why?
|
| Mutation | 1 | 1995 | 30228 | 0.000 |
Why?
|